Semnur Pharmaceuticals Inc SMNR
Trading Information
- Previous Close Price
- $0.25
- Day Range
- $0.02–0.23
- 52-Week Range
- $0.02–23.00
- Bid/Ask
- $0.01 / $0.36
- Shares Outstanding
- 217.71M
- Market Cap
- $34.53M
- Volume/Avg
- 81,053 / 7,250
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 29
- Website
- https://www.semnurpharma.com
Valuation
Metric | SMNR |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | SMNR |
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
SMNR
Profitability
Metric | SMNR |
|---|---|
Return on Assets (Normalized) | −811.34% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SMNR
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|rL^&x< | LOCK|XP?<$ | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|J#D>Hy | LOCK|ctQj$ | $95B | |||
| Moderna Inc MRNA | LOCK|YlRYyv@ | LOCK|Nd | $79B | |||
| argenx SE ADR ARGX | LOCK|wT###z | LOCK|Wx | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|dFp&y$ | LOCK|H$@ | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|^>@^>d% | LOCK|!J#L | $30B | |||
| Incyte Corp INCY | LOCK|m#Dn$!? | LOCK|F& | $23B | |||
| BioNTech SE ADR BNTX | LOCK|JfHDs% | LOCK|b$h | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|WNy#yqN | LOCK|nMn^ | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|^>gqg#s | LOCK|#gD | $15B |